Nebraska 2025 Session Status: To Executive

LB195 — The official site of the Nebraska Unicameral Legislature

Last action — Approved by Governor on April 7, 2025

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Legislature
  4. 4
    To Executive
  5. 5
    Enacted

This bill has been sent to the executive. Introduced January 14, 2025. It awaits signature.

Signed by Governor Jim Pillen (Republican) on April 03, 2025.

Next likely step: the executive signs it into law or issues a veto.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • To Executive

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

Bill Text

We don't have the full text on file for this bill yet.

Read LB195 on the official Nebraska source →

Action History

  1. Date of introduction

  2. Referred to Judiciary Committee

  3. Notice of hearing for January 23, 2025

  4. Placed on General File with AM135

  5. Judiciary AM135 filed

  6. Hallstrom name added

  7. Bosn AM240 to AM135 filed

  8. Bosn AM240 adopted

  9. Judiciary AM135 adopted

  10. Advanced to Enrollment and Review Initial

  11. Placed on Select File

  12. Advanced to Enrollment and Review for Engrossment

  13. Placed on Final Reading

  14. Passed on Final Reading 47-0-2

  15. President/Speaker signed

  16. Presented to Governor on April 3, 2025

  17. Approved by Governor on April 7, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 48 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (48)

48 members have not signed on to this bill.

Show all 48 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does LB195 do?
Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications
Who sponsors LB195?
LB195 is sponsored by Glen Meyer.
What is the current status of LB195?
This bill has been sent to the executive. Introduced January 14, 2025. It awaits signature.
Where can I track LB195?
Track LB195 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on LB195

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of LB195

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →